TMO
Status-Quo-PlayerThermo Fisher Scientific
$514.23
+3.65%
as of 13 Apr
Power Core
The moat in one sentence: Thermo Fisher's power derives from the regulatory and procedural switching costs created when laboratories validate their workflows on its instruments and consumables, creating infrastructure-level lock-in across the global research and clinical ecosystem.
Direction of Movement
Lateral With Conditions for Re-Acceleration
ROC 200
+21.3%
TMO
Thermo Fisher Scientific
$514.23
+3.65%
as of 13 Apr
DCF Fair Value: $525.57
Market data unavailable
Company Profile
Thermo Fisher Scientific Inc. is a leading provider of life sciences solutions, analytical instruments, specialty diagnostics, laboratory products, and biopharma services worldwide. The company serves pharmaceutical and biotech companies, hospitals, clinical diagnostic labs, universities, research institutions, government agencies, and sectors including environmental, industrial, research and development, quality, and process control. Its Life Sciences Solutions segment delivers reagents, instruments, and consumables for biological and medical research, drug and vaccine discovery and production, and disease diagnosis. The Analytical Instruments segment supplies tools, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and industrial applications, as well as clinical labs. Additional offerings include lab products, services through brands like Fisher Scientific and Unity Lab Services, and biopharma capabilities via Patheon and PPD. Thermo Fisher Scientific Inc., headquartered in Waltham, Massachusetts, supports customers across North America, Europe, and Asia-Pacific with innovative technologies and global distribution.